VRXA

Veraxa Biotech AG

1.31

Sep 29 • 3:59 PM ET -0.06 (-4.38%)

1.33

Aftermarket • 6:04 PM ET +0.02 (1.53%)

Healthcare Biotechnology Switzerland Micro NASD

Peers: CNTX INKT XLO ATYR BOLD MCRB DWTX IMMP PMVP EDSA

| Held by: ONEQ

Index	-
Market Cap	193.53M
Enterprise Value	193.50M
Income	6.74M
Sales	0.00M
Book/sh	-2.25
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3
IPO	Sep 30, 2024

P/E	6.12
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	6450.87
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.00
Current Ratio	0.00
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	0.21
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	2.24%
Sales Y/Y TTM	-
EPS Q/Q	-91.03%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	75.11%
Insider Trans	0.05%
Inst Own	0.33%
Inst Trans	56.08%
ROA	2.52%
ROE	5.72%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-12.29%
SMA50	-22.66%
SMA200	-83.75%
Trades

Shs Outstand	147.73M
Shs Float	36.77M
Short Float	0.57%
Short Ratio	0.43
Short Interest	0.21M
52W High	27.36 -95.21%
52W Low	1.27 3.15%
Volatility	5.13% 9.48%
ATR (14)	0.15
RSI (14)	33.12
Beta	0.15
Rel Volume	0.11
Avg Volume	493.44K
Volume	53,072

Perf Week	-7.09%
Perf Month	-2.96%
Perf Quarter	-30.32%
Perf Half Y	-89.31%
Perf YTD	-87.72%
Perf Year	-87.46%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	1.37
Price	1.31
Change %	-4.38%

Sep-24-26 03:38PM	VERAXA Biotech (VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress (NewMediaWire)
Sep-22-26 02:30PM	VERAXA Biotech (VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase (NewMediaWire)
Sep-18-26 03:30PM	VERAXA Biotech (VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline (NewMediaWire)
Sep-16-26 03:00PM	VERAXA Biotech (VRXA) Building a New Approach to Precision Cancer Therapy (NewMediaWire)
Sep-09-26 11:46AM	VERAXA Biotech Designates Raju Willener as CFO (Exec Edge)
02:34PM	Loading…
Sep-08-26 02:34PM	VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer (NewMediaWire) -9.09%
Sep-04-26 07:00AM	VERAXA Biotech Appoints Raju Willener as Chief Financial Officer (GlobeNewswire) +15.03%
Aug-28-26 03:00PM	VERAXA Biotech (VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology (NewMediaWire) -6.25%
Aug-24-26 02:00PM	VERAXA Biotech (VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision (NewMediaWire) -8.72%
07:00AM	VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance (GlobeNewswire)
Aug-06-26 02:30PM	VERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies (NewMediaWire)
Jul-30-26 02:15PM	VERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform (NewMediaWire)
Jul-29-26 03:30PM	VERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms (NewMediaWire)
07:00AM	VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates (GlobeNewswire)
Jul-28-26 01:45PM	VERAXA Biotech (VRXA) Shareholders Approve Corporate Governance, Financing Measures (NewMediaWire)
03:37PM	Loading…
Jul-27-26 03:37PM	VERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration (NewMediaWire) +11.67%
07:00AM	VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb (GlobeNewswire)
Jul-24-26 04:05PM	VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth (GlobeNewswire)
02:30PM	VERAXA Biotech AG (VRXA) Appoints Christoph Erkel as Chief Scientific Officer (NewMediaWire)
Jul-23-26 02:30PM	VERAXA Biotech (VRXA) Advances BiTAC(R)-TCE Development With Positive Regulatory Feedback From Germany (NewMediaWire) -9.27%
07:00AM	VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Technology Platforms and Portfolio (GlobeNewswire)
Jul-20-26 03:30PM	VERAXA Biotech (VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform (NewMediaWire)
07:00AM	VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan (GlobeNewswire)
Jul-15-26 02:40PM	Why VERAXA Biotech (VRXA) Could Benefit More Than Others From AI's Growing Impact on Drug R&D (NewMediaWire)
Jul-13-26 03:30PM	VERAXA Biotech (VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development (NewMediaWire)
07:00AM	VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC Pipeline (GlobeNewswire)
Jul-10-26 04:05PM	VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Burgermeister (GlobeNewswire) -11.29%
Jul-09-26 02:30PM	VERAXA Biotech (VRXA) Advances Lead BiTAC(R) T-Cell Engager Program With Cell Line Development Partnership (NewMediaWire) -10.14%
Jul-06-26 03:00PM	VERAXA Biotech (VRXA) Highlights BiTAC Pipeline Progress, Advances Partnering Strategy (NewMediaWire) +7.35%
12:00PM	The Cancer Therapy Strategy VERAXA Is Betting the Company On (Exec Edge)
07:00AM	Loading…
07:00AM	VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines (GlobeNewswire)
Jul-02-26 06:40PM	VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone (Exec Edge) +18.26%
03:30PM	VERAXA Biotech (VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program (NewMediaWire)
07:00AM	VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC-TCE Program (GlobeNewswire)
Jul-01-26 03:45PM	Why VERAXA Biotech (VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals (NewMediaWire) -8.24%
Jun-25-26 03:04PM	VERAXA Biotech (VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline (NewMediaWire)
Jun-24-26 02:30PM	VERAXA Biotech (VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline (NewMediaWire) -20.96%
02:15PM	VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical Development (Exec Edge)
07:00AM	VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC-TCE and ADC Programs Advance Towards Clinical Development (GlobeNewswire)
Jun-22-26 02:30PM	VERAXA Biotech (VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention (NewMediaWire) -7.59%
Jun-19-26 10:56AM	VERAXA Biotech (VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform (NewMediaWire)
Jun-18-26 10:34AM	VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 (Exec Edge) -23.55%
07:00AM	VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026 (GlobeNewswire)
Jun-17-26 03:30PM	Why VERAXA Biotech AG (VRXA) Is 'One to Watch' (NewMediaWire) -38.05%
Jun-12-26 03:00PM	VERAXA Biotech (VRXA) Is 'One to Watch' (NewMediaWire) -19.32%
Jun-11-26 03:30PM	VERAXA Biotech (VRXA) Completes Business Combination, Begins Trading on Nasdaq (NewMediaWire) +44.85%

Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.

Co-FounderDr. Christoph Antz Ph.D.

Interim CFOMr. Carl von Halem

Chief Scientific OfficerDr. Christoph Erkel Ph.D.

Ph.D.Dr. Heinz Schwer M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Baumann Oliver Rolf	Director	Aug 27 '26	Buy	1.50	50,000	75,000	5,773,618	Aug 31 04:10 PM
Antz Christoph Rudiger	Chief Executive Officer	Aug 27 '26	Buy	1.53	5,000	7,650	5,000	Aug 31 04:10 PM

Open in Screener

NUTX

Nutex Health Inc

210.10

Sep 29 • 3:59 PM ET -2.63 (-1.24%)

210.10

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Care Facilities USA Small NASD

Peers: ARDT CYH UHS MD HCA THC BKD CHE ENSG PACS

| Held by: AVUV VTI IWM VXF IWO CALF SFLO BSVO VTWO SCHA

Index	RUT
Market Cap	1.44B
Enterprise Value	1.69B
Income	179.92M
Sales	846.72M
Book/sh	57.62
Cash/sh	30.24
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	944
IPO	Apr 24, 2014

P/E	8.31
Forward P/E	7.54
PEG	0.22
P/S	1.70
P/B	3.65
P/C	6.95
P/FCF	5.25
EV/EBITDA	4.39
EV/Sales	2.00
Quick Ratio	4.96
Current Ratio	5.00
Debt/Eq	0.88
LT Debt/Eq	0.83
Option/Short	No / Yes

EPS (ttm)	25.28
EPS next Y	27.87
EPS next Q	5.71
EPS this Y	165.21%
EPS next Y	0.28%
EPS next 5Y	34.22%
EPS past 3/5Y	- -
Sales past 3/5Y	58.62% 253.48%
EPS Y/Y TTM	155.98%
Sales Y/Y TTM	6.88%
EPS Q/Q	417.67%
Sales Q/Q	-13.62%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	89.34% -1.99%

Insider Own	32.87%
Insider Trans	-0.01%
Inst Own	43.18%
Inst Trans	1.12%
ROA	19.93%
ROE	57.16%
ROIC	24.87%
Gross Margin	51.26%
Oper. Margin	43.02%
Profit Margin	21.25%
SMA20	2.83%
SMA50	13.90%
SMA200	43.21%
Trades

Shs Outstand	6.84M
Shs Float	4.60M
Short Float	26.83%
Short Ratio	8.18
Short Interest	1.23M
52W High	224.28 -6.32%
52W Low	83.99 150.15%
Volatility	5.56% 5.49%
ATR (14)	11.12
RSI (14)	56.33
Beta	0.55
Rel Volume	0.98
Avg Volume	150.79K
Volume	147,658

Perf Week	0.61%
Perf Month	11.02%
Perf Quarter	22.94%
Perf Half Y	131.13%
Perf YTD	27.63%
Perf Year	97.78%
Perf 3Y	591.69%
Perf 5Y	-67.04%
Perf 10Y	-96.89%
Recom	1.00
Target Price	288.20
Prev Close	212.74
Price	210.10
Change %	-1.24%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-04-26	Resumed	B. Riley Securities	Buy	$325
Jun-26-26	Initiated	B. Riley Securities	Buy	$290
Jun-02-26	Initiated	Lake Street	Buy	$235
Nov-12-24	Reiterated	Maxim Group	Buy	$45 → $50
Sep-18-24	Initiated	Maxim Group	Buy	$45
Feb-22-23	Initiated	Northland Capital	Outperform	$3

Sep-22-26 06:50PM	Nutex Health Approved for Dual Listing on Nasdaq Texas (PR Newswire)
Sep-10-26 07:00PM	NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT (PR Newswire)
Aug-31-26 05:30AM	Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026 (PR Newswire)
Aug-25-26 05:30AM	Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act (PR Newswire)
Aug-18-26 05:30AM	NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS (PR Newswire)
09:04PM	Loading…
Aug-14-26 09:04PM	Nutex Health Inc (NUTX) (Q2 2026) Earnings Call Highlights: Net Income Soars 3,100% as Revenue ... (GuruFocus.com)
Aug-07-26 08:30AM	Nutex Health, Inc. Q2 2026 Earnings Call Summary (Moby) +6.67%
Aug-06-26 05:58PM	NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS (PR Newswire)
Jul-21-26 05:30AM	Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call (PR Newswire)
May-01-26 08:30AM	Nutex Health, Inc. Q1 2026 Earnings Call Summary (Moby) +17.09%
Apr-30-26 05:15PM	NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS (PR Newswire) +6.41%
Apr-22-26 04:15PM	Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call (PR Newswire)
Mar-11-26 09:04PM	Nutex Health Inc (NUTX) Q4 2025 Earnings Call Highlights: Robust Annual Growth Amid Quarterly ... (GuruFocus.com) -6.50%
Mar-06-26 04:42PM	Stocks Retreat on Inflation Concerns and a Weak US Job Market (Barchart) -14.30% +9.23%
02:08PM	Nutex Health Q4 Earnings Call Highlights (MarketBeat)
11:18AM	Loading…
11:18AM	Stocks Retreat Amid Inflation Fears and Weak US Jobs (Barchart)
10:05AM	Stocks Slump on Iran War and Weak US Jobs Report (Barchart)
08:30AM	Nutex Health, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-05-26 06:33PM	NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM (PR Newswire)
Feb-25-26 05:29PM	Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call (PR Newswire) +9.36% +6.73%
Feb-04-26 01:41PM	Nutex Health Inc. (NUTX): A Bull Case Theory (Insider Monkey) -19.01%
Jan-12-26 05:30AM	NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON (PR Newswire)
Jan-07-26 11:02AM	Healthcare and technology stocks are driving up the Nasdaq (MarketWatch)
Jan-05-26 05:30AM	NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO (PR Newswire) +13.13%
Jan-02-26 12:41PM	This Health Name Gains Over 400% In 2025. A Gold Stock Is Right Behind It. (Investor's Business Daily) -9.98%
Dec-26-25 03:40PM	Medical Stocks On The Move In Top Growth List As Health Sector Performance Brightens (Investor's Business Daily) +5.10%
Dec-22-25 05:30AM	NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS (PR Newswire)
Dec-04-25 05:30AM	NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN (PR Newswire) +19.01%
Dec-01-25 07:15AM	Nutex Health Inc (NUTX) Q3 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-26-25 04:10PM	NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT (PR Newswire) -5.38%
10:02PM	Loading…
Nov-24-25 10:02PM	Thousands to treat a runny nose? New Post Falls hospital's billing practices under scrutiny (The Spokesman-Review, Spokane, Wash.) -13.12%
04:38PM	NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS (PR Newswire)
Nov-21-25 10:06PM	Thousands to treat a runny nose? New Post Falls hospital's billing practices under scrutiny (The Spokesman-Review, Spokane, Wash.)
Nov-19-25 04:30PM	NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS (PR Newswire) +13.09% +26.87%
Nov-18-25 06:59PM	NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS (PR Newswire)
06:50PM	NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
06:26PM	NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS (PR Newswire)
Oct-20-25 05:30AM	NUTEX HEALTH PROVIDES CORPORATE UPDATE (PR Newswire) +17.05%
Oct-17-25 09:19AM	Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman (PR Newswire)
08:45AM	Investors in Nutex Health Inc. Should Contact Levi & Korsinsky Before October 21, 2025 to Discuss Your Rights - NUTX (PR Newswire)
Oct-15-25 02:22PM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman (Business Wire) +6.57%
Oct-14-25 10:16PM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman (PR Newswire)
Oct-13-25 04:52PM	Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX (PR Newswire) +7.73%
Oct-10-25 09:45AM	Shareholders of Nutex Health Inc. (NUTX): Protect Your Rights Before October 21, 2025 - Contact Levi & Korsinsky (Newsfile) -8.54%
09:30AM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman (PR Newswire)
09:00AM	Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NUTX (PR Newswire)
Oct-09-25 12:37PM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman (Newsfile)
Oct-07-25 07:56AM	Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX (PR Newswire) -5.39%
Oct-06-25 05:30AM	Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3 (PR Newswire)
Oct-03-25 02:28PM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman (Newsfile)
Oct-02-25 08:28AM	Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX (PR Newswire)
Sep-25-25 03:35PM	Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman (Newsfile)
11:12AM	Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights NUTX (Business Wire)
Sep-22-25 06:30AM	NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER (PR Newswire)
Sep-18-25 06:08PM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman (Newsfile)
Sep-04-25 09:30AM	Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman (PR Newswire)
Aug-28-25 08:18AM	Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements -- Hagens Berman (Newsfile)
Aug-26-25 09:05AM	Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman (PR Newswire)
Aug-20-25 06:51PM	NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE (PR Newswire)
Aug-19-25 12:42PM	Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report -- Hagens Berman (Newsfile)
Aug-14-25 05:10PM	NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION (PR Newswire) +5.65% -16.40%
09:21AM	What To Expect From Nutex Health Inc (NUTX) Q2 2025 Earnings (GuruFocus.com)
Aug-08-25 08:49AM	Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call (PR Newswire)
Jul-29-25 06:30AM	NUTEX HEALTH TO RING NASDAQ BELL AND MEET WITH INVESTORS IN NYC ON AUGUST 26 (PR Newswire) -7.56%
Jul-28-25 11:31AM	Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman (PR Newswire)
Jul-23-25 08:32PM	Nutex Health Responds to Short Seller Report (PR Newswire) -7.11%
10:54AM	Jim Cramer Says Nutex "Might Need a New Catalyst" to See More Upside (Insider Monkey)
Jul-22-25 02:13PM	Blue Orca Capital takes short position in Nutex Health (Investing.com) -10.05%
Jul-08-25 06:30AM	NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS (PR Newswire) +9.62%
Jun-27-25 06:30AM	NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT (PR Newswire)
Jun-24-25 06:30AM	NUTEX HEALTH INC. ADDED TO RUSSELL 3000 INDEX AND RUSSELL MICROCAP INDEX (PR Newswire)
Jun-02-25 10:18PM	NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING (PR Newswire) -11.80%
May-22-25 06:30AM	NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR (PR Newswire)
May-15-25 05:00PM	Nutex Health Inc (NUTX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... (GuruFocus.com) +9.42%
May-13-25 05:43PM	NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS (PR Newswire) +26.10%
09:33AM	What To Expect From Nutex Health Inc (NUTX) Q1 2025 Earnings (GuruFocus.com)
May-12-25 09:29AM	Earnings To Watch: Nutex Health Inc (NUTX) Reports Q1 2025 Result (GuruFocus.com)
May-07-25 06:30AM	Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call (PR Newswire) -11.62%
Apr-30-25 06:00AM	Why Nutex Health Inc. (NUTX) is Surging in 2025 (Insider Monkey)
Apr-21-25 05:58PM	Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout (Insider Monkey)
Apr-02-25 04:15AM	Nutex Health Achieves Blowout Earnings On Arbitration Win But There Are Too Many Unknowns (Seeking Alpha) +5.13%
03:01AM	Nutex Health Inc (NUTX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion (GuruFocus.com)
Apr-01-25 04:34PM	Nutex Health Inc. (NUTX) Q4 2024 Earnings Call Transcript (Seeking Alpha) +51.82%
Mar-31-25 04:30PM	NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS (PR Newswire) -9.00%
Mar-27-25 06:28PM	NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL (PR Newswire) -7.12%
Mar-20-25 05:30AM	Nutex Health to Present at the EDPMA Solutions Summit 2025 (PR Newswire)
Mar-17-25 05:30AM	NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL (PR Newswire)
Feb-05-25 05:30AM	Nutex Health Issues No Surprises Act (NSA) Arbitration Update (PR Newswire) +12.82%
Jan-21-25 05:30AM	Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4 (PR Newswire)
Jan-13-25 05:30AM	NUTEX HEALTH OPENS STARKEY RANCH ER and HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA (PR Newswire)
05:30AM	NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA (PR Newswire)
Jan-06-25 05:30AM	NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Nov-18-24 05:30AM	NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN (PR Newswire)
Nov-07-24 05:09PM	NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS (PR Newswire) +6.33% +9.24%
07:11AM	Earnings To Watch: Nutex Health Inc (NUTX) Reports Q3 2024 Result (GuruFocus.com)
Nov-06-24 07:48AM	What To Expect From Nutex Health Inc (NUTX) Q3 2024 Earnings (GuruFocus.com) +8.68%
Nov-05-24 05:30AM	NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL (PR Newswire) +8.51%
Nov-01-24 05:30AM	NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL (PR Newswire)
Sep-30-24 05:30AM	NUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS IN THE 3rd QUARTER OF 2024 (PR Newswire) +11.28%
Aug-26-24 05:30AM	NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO (PR Newswire) +11.84%

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

M.D.Dr. Thomas T. Vo M.B.A.

President & DirectorDr. Warren Hosseinion M.D.

M.B.A.Mr. Jon C. Bates CPA

Chief Operating OfficerMr. Wesley Bamburg FACHE

Chief Medical OfficerDr. Michael Chang M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saunders Scott J	Director	Sep 18 '26	Sale	214.25	203	43,493	400	Sep 18 02:51 PM
Jaumot Frank E	Director	Jul 31 '26	Option Exercise	0.00	603	0	753	Aug 03 10:10 AM
Grenas Cheryl Yvonne	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03 10:07 AM
Saunders Scott J	Director	Jul 31 '26	Option Exercise	0.00	603	0	603	Aug 03 10:04 AM
Reed Michael Lee	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03 09:59 AM
Hosseinion Warren	President	Mar 19 '26	Buy	94.07	252	23,706	7,765	Mar 23 01:21 PM
Jaumot Frank E	Director	Mar 20 '26	Buy	93.56	150	14,033	150	Mar 23 01:11 PM
Spears Kelvin	Director	Mar 17 '26	Buy	94.46	10	945	32,137	Mar 18 10:40 AM
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 13 '26	Buy	88.87	79	7,021	2,758	Mar 16 03:02 PM
Luqman Elisa V	Chief Legal Officer - SEC	Mar 10 '26	Option Exercise	0.00	2,084	0	3,154	Mar 11 06:27 PM
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 10 '26	Option Exercise	0.00	2,084	0	3,455	Mar 11 06:08 PM
Spears Kelvin	Director	Mar 10 '26	Option Exercise	0.00	183	0	32,209	Mar 11 05:52 PM
Chang Michael L.	Chief Medical Officer	Mar 10 '26	Option Exercise	0.00	2,084	0	83,125	Mar 11 05:36 PM
Hosseinion Warren	President	Mar 10 '26	Option Exercise	0.00	6,293	0	10,787	Mar 11 05:20 PM
Vo Thomas T.	Chief Executive Officer	Mar 10 '26	Option Exercise	0.00	8,334	0	1,846,213	Mar 11 05:01 PM
Bates Jon Christian	Chief Financial Officer	Mar 10 '26	Option Exercise	0.00	2,667	0	8,305	Mar 11 04:35 PM
Bates Jon Christian	Chief Financial Officer	Nov 25 '25	Buy	136.71	750	102,532	5,638	Nov 28 02:11 PM

VRXA

Veraxa Biotech AG

NUTX

Nutex Health Inc

Upgrade your Finviz experience